source
- Swedish biotech AnaCardio secures $70.9M Series B to advance heart failure drugSwedish biotech AnaCardio announced a Series B financing round that raised €62.5 million ($70.9 million). The capital will be used to move its chronic advanced heart failure drug toward registrati…
- Child health crisis threatens US national security, authors warnThe authors argue that chronic illness, anxiety, depression and other health problems among children undermine future military readiness, the workforce and the nation’s global competitiveness. The…